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ABSTRACT
Background Although maternal psychological distress 
during pregnancy is associated with increased risks of 
respiratory morbidity in preschool children, it is unknown 
whether this association persists into later childhood.
Objective To examine the association between 
parental psychological distress during pregnancy and 
lung function and asthma in children of school age.
Methods This study of 4231 children was embedded 
in a population- based prospective cohort. Parental 
psychological distress was assessed by the Brief 
Symptom Inventory during and 3 years after pregnancy, 
and in mothers also at 2 and 6 months after pregnancy. 
At age 10 years, lung function was obtained by 
spirometry and asthma by questionnaire.
Results The prevalence of asthma was 5.9%. Maternal 
overall psychological distress during pregnancy was 
associated with a lower forced vital capacity (FVC) 
(z- score difference −0.10 (95% CI −0.20 to –0.01) per 
1- unit increase), maternal depressive symptoms during 
pregnancy with a lower forced expiratory volume in 
the first second (FEV1) and FVC (−0.13 (95% CI −0.24 
to –0.01) and −0.13 (95% CI −0.24 to –0.02) when 
using clinical cut- offs) in their children. All maternal 
psychological distress measures during pregnancy were 
associated with an increased risk of asthma (range OR: 
1.46 (95% CI 1.12 to 1.90) to 1.91 (95% CI 1.26 to 
2.91)). Additional adjustment for paternal psychological 
distress during pregnancy and parental psychological 
distress after pregnancy did not materially change the 
associations. Paternal psychological distress during 
pregnancy was not associated with childhood respiratory 
morbidity.
Conclusion Maternal, but not paternal, psychological 
distress during pregnancy is associated with an increased 
risk of asthma and partly lower lung function in children. 
This suggests intrauterine programming for the risk of 
later- life respiratory disease.
INTRODUCTION
Early life is a sensitive period for the development 
of respiratory health.1 We and others have previ-
ously shown that maternal psychological distress 
during pregnancy is associated with increased risks 
of wheezing and asthma in their preschool- aged 
children.2–7 This suggests a potential role of intra-
uterine mechanisms, such as altered programming 
of the fetal hypothalamic–pituitary–adrenal (HPA) 
axis, leading to adaptive airway and lung develop-
ment and asthma.8–10 The association of maternal 
psychological distress during pregnancy with child-
hood asthma might also be explained by residual 
confounding factors such as unmeasured genetic, 
social, behavioural or environmental factors. Since 
these residual confounding factors are shared by 
mother and father, while only maternal psycho-
logical distress might have intrauterine effects, 
examining paternal psychological distress during 
pregnancy in relation to childhood asthma is 
of importance to account for these residual 
confounders.3 11 Only a few studies have measured 
paternal psychological distress, and they found that 
this is not associated with an increased risk of respi-
ratory symptoms in early childhood, suggesting 
an intrauterine effect.2 3 7 To date, the associations 
of maternal and paternal psychological distress 
during pregnancy with asthma in later childhood 
and the association with lung function are not fully 
clear.12 13 We hypothesise that maternal psycho-
logical distress during pregnancy, but not paternal 
psychological distress, is associated with lower 
lung function and asthma in school- age children, 
suggesting intrauterine programming for the risk of 
respiratory disease.
Key messages
What is the key question?
 ► Is parental psychological distress during 
pregnancy associated with lung function and 
asthma at school age?
What is the bottom line?
 ► Maternal, but not paternal, psychological 
distress during pregnancy is associated with an 
increased risk of asthma and partly lower lung 
function in children.
Why read on?
 ► These findings may indicate an intrauterine 
effect of maternal psychological distress during 
pregnancy on fetal lung development and 
respiratory morbidity rather than an effect of 
unmeasured genetic, social, behavioural or 
environmental factors.
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We therefore examined the association between maternal 
psychological distress during pregnancy and lung function and 
asthma in children aged 10 years in a population- based prospec-
tive study. We also assessed whether these associations were 
independent of paternal psychological distress during pregnancy 
and parental psychological distress after pregnancy.
METHODS
Design
This study was embedded in the Generation R Study, a 
population- based prospective cohort study from early fetal life 
onwards in Rotterdam, the Netherlands.14 The study has been 
approved by the Medical Ethical Committee of the Erasmus 
MC, University Medical Centre in Rotterdam. Written informed 
consent was obtained from all parents or legal guardians of the 
participants. Children from twin pregnancies (n=185), with 
missing information on maternal psychological distress during 
pregnancy (n=1964) or missing information on both lung func-
tion and asthma (n=1013) were excluded, which left a total of 
4231 subjects at age 10 years for the current analyses (online 
supplementary figure S1).
Maternal and paternal psychological distress
Maternal and paternal psychological distress was assessed by 
questionnaires completed in the second trimester of preg-
nancy and 3 years after pregnancy. Both parents were asked 
to complete their own questionnaires. At 2 and 6 months after 
pregnancy, only maternal psychological distress was assessed. 
We used the Brief Symptom Inventory, a validated 53- item self- 
report questionnaire covering a broad spectrum of psychological 
distress experienced in the last 7 days.15 16 A global scale (Global 
Severity Index (GSI)) and nine symptom scales were defined.17 18 
The GSI is a measure of the current level or the depth of symp-
toms and denotes overall psychological distress. Of the symptom 
scales, we used the depressive and anxiety symptom scale only 
since, in general, depression and anxiety are considered the most 
common psychological distress during and after pregnancy. Other 
subscales encompass less prevalent disorders such as somatisa-
tion, obsessive- compulsion, interpersonal sensitivity, hostility, 
phobia, paranoia and psychoticism. All scales were repeated at 
2 months after pregnancy and, at 6 months and 3 years after 
pregnancy only depressive and anxiety symptom scales were 
used. All items (53 for the GSI and 6 for both the depressive and 
anxiety symptom scales) were rated on a 5- point unidimensional 
scale ranging from 0 (‘not at all’) to 4 (‘extremely’). Total scores 
for each scale were calculated by summing the item scores and 
dividing this by the number of endorsed items. Based on Dutch 
cut- off values, mothers and fathers were categorised as having 
clinically relevant psychological distress (no; yes) when having 
a score of ≥0.71 or ≥0.66 on the global scale, ≥0.80 or ≥0.71 
on the depressive symptom scale and ≥0.71 or ≥0.65 on the 
anxiety symptom scale, respectively.19 The Cronbach’s alpha, 
reflecting internal consistency of the different scales, ranged 
from 0.72 to 0.93, which is considered acceptable to excellent. 
Spearman correlations between parental psychological distress 
during and after pregnancy varied between 0.29 and 0.45 (weak 
to moderate), and between maternal and paternal psychological 
distress between 0.12 and 0.23 (very weak to weak).
Lung function and asthma in school-age children
Lung function was measured by spirometry at the age of 10 years 
(median 9.7 (5%–95% range 9.5–10.3)), as reported earlier.20 
In short, forced expiratory volume in 1 s (FEV1), forced vital 
capacity (FVC), FEV1/FVC and forced expiratory flow after 
exhaling 75% of FVC (FEF75) were measured in accordance 
with the American Thoracic Society (ATS) and European Respi-
ratory Society (ERS) recommendations and converted into 
sex-, height-, age- and ethnicity- adjusted z- scores according to 
the Global Lung Initiative reference data.21 22 Additionally, we 
included 281 children whose spirometry did not meet formal 
reproducibility criteria but who had at least one adequate curve 
with respect to reach and duration of the plateau according to 
ATS/ERS criteria. Observed sizes and direction of effect esti-
mates were similar to when these children were excluded.23 
Current asthma was defined as ever diagnosis of asthma, with 
either wheezing or any asthma medication use in the past 12 
months at the age of 10 years. Information on asthma diagnosis 
and wheezing was obtained by a parental questionnaire based 
on the International Study on Asthma and Allergy in Childhood 
(ISAAC) Questionnaire (“Has your child ever had asthma diag-
nosed by a doctor?” and “Has your child suffered from attacks 
of wheezing in the chest in the past 12 months?”).24 Information 
on asthma medication use was obtained during the visit to our 
research centre.
Covariates
Information on maternal characteristics included age, parity, 
ethnicity, educational level, smoking during pregnancy, body 
mass index at enrolment, history of asthma and atopy and pet 
keeping, and were obtained from multiple questionnaires during 
pregnancy. Information on paternal characteristics included age, 
ethnicity, educational level, smoking before pregnancy, body 
mass index at enrolment and history of asthma and atopy, and 
were obtained by a questionnaire during pregnancy. Informa-
tion on child’s sex, gestational age at birth, and birth weight was 
obtained from midwife and hospital records. Information on 
child’s ethnicity was based on questionnaires during pregnancy, 
and information on breastfeeding and daycare attendance were 
obtained by questionnaires in the first year of life. Additional 
information on confounders can be found in the online supple-
mental methods.
Statistical analysis
First, we compared the characteristics of children included in 
and excluded from our study due to loss to follow- up using 
Mann–Whitney U tests, t- tests and χ2 tests. Second, we used 
linear and logistic regression models to study the associations 
of maternal psychological distress during pregnancy with lung 
function and current asthma, respectively. Overall psycholog-
ical distress, depressive and anxiety symptoms were studied 
separately, and both continuous measures and clinical cut- offs 
were used. Analyses were adjusted for confounders, which were 
first selected from the literature and subsequently included in 
the model if they were associated with maternal psycholog-
ical distress and lung function or asthma, or if the effect sizes 
of unadjusted analyses changed 10% or more after adding 
a confounder (main model). All confounders selected from 
the literature met these criteria, and we therefore included 
all confounders in the model. A directed acyclic graph of the 
confounders is shown in online supplementary figure S2. Addi-
tionally, we added paternal psychological distress during preg-
nancy to the model to minimise the potential correlated effect 
of maternal and paternal psychological distress during preg-
nancy on childhood lung function and asthma, and to assess 
the individual effect of maternal psychological distress during 
pregnancy. Next, we added maternal psychological distress 
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after pregnancy to the main model as a mediator to disentangle 
the individual effect of maternal psychological distress during 
pregnancy on respiratory morbidity of the child. We assessed 
the change in effect estimates for the associations of maternal 
psychological distress during pregnancy with lung function and 
asthma, after additional adjustment for maternal psychological 
distress after pregnancy, by using the following formulae for 
percentage change: 100 * (Effect estimatefull model – Effect esti-
mateoriginal model)/(Effect estimateoriginal model) for continuous lung 
function measures, and 100 * (Effect estimatefull model – Effect 
estimateoriginal model)/(Effect estimateoriginal model – 1) for categorical 
asthma. All other confounders were kept similar to the model 
with only maternal distress during pregnancy, to ascertain that 
the change in effect estimate is only due to the additional adjust-
ment for parental psychological distress after pregnancy.
To assess residual confounding effects of unmeasured genetic, 
social, behavioural or environmental factors, we studied the 
associations of paternal psychological distress during preg-
nancy with lung function and asthma. Additionally, we adjusted 
the associations for paternal psychological distress after preg-
nancy including change in effect estimates similar to maternal 
psychological distress. Since parental psychological distress after 
pregnancy is likely to be correlated to parental distress during 
pregnancy, adding psychological distress after pregnancy to the 
model could lead to multicollinearity. Correlations between 
parental psychological distress during and after pregnancy were, 
however, below 0.5. Additionally, we assessed the Variance 
Inflation Factor and tolerance statistics (which are measures for 
multicollinearity) of the models where parental psychological 
distress after pregnancy was added to parental psychological 
distress during pregnancy. Both these measures showed no indi-
cation for multicollinearity and inflation of the model. Lastly, we 
performed a sensitivity analysis focusing on patterns of depres-
sive and anxiety symptoms. In this analysis, depressive and 
anxiety symptoms during and after pregnancy were combined 
into the following groups: never, symptoms during pregnancy 
only, symptoms after pregnancy only, and both symptoms during 
and after pregnancy. Symptoms after pregnancy reflect psycho-
logical distress at either 2, 6 or 36 months after pregnancy.
Missing data in covariates (range between 0% and 33%), 
maternal psychological distress after pregnancy and paternal 
psychological distress during and after pregnancy (range between 
26% and 41%) were imputed by multiple imputation using the 
Markov Chain Monte Carlo method.25 We only present the 
pooled results based on the imputed datasets, since we observed 
no major differences in the magnitude or direction of the effect 
when compared with complete case analysis. All measures of 
association are presented with their 95% CIs. Statistical analyses 
were performed using SPSS Version 24.0 for Windows software 
and R version 3.4.1.
RESULTS
Characteristics of subjects
Parental and child characteristics are shown in tables 1 and 2, 
respectively. A total of 362 (8.6%) of the participating mothers 
and 167 (3.9%) of the participating fathers had clinically rele-
vant overall psychological distress. The mean (SD) values for 
FEV1, FVC, FEV1/FVC and FEF75 were 2.02 (0.30) L, 2.33 (0.36) 
L, 86.72 (5.66)% and 1.15 (0.35) L/s, respectively. The prev-
alence of current asthma in children aged 10 years was 5.9% 
(n=213). Most prominently, children lost to follow- up more 
often had non- European parents and a lower gestational age at 
birth and birth weight (online supplementary table S1).
Maternal psychological distress, lung function and asthma
Unadjusted associations of maternal psychological distress during 
pregnancy with lung function and asthma in school- age children 
are shown in online supplementary table S2. After adjustment 
for confounders and when studied continuously, only maternal 
overall psychological distress during pregnancy was associated 
with a lower FVC (z- score difference −0.10 (95% CI −0.20 to 
–0.01)) in their children (table 3). When using clinical cut- offs, 
Table 1 Characteristics of mothers and fathers
n=4231
Mothers Fathers
Mean (SD) age, years 30.9 (4.8) 33.4 (5.6)
Parity, nulliparous 59.5 (2516) –
Ethnicity, non- European 31.4 (1329) 35.6 (1507)
Education, lower 48.1 (2034) 48.9 (2068)
Smoking during pregnancy, yes 26.5 (1122) –
Smoking before pregnancy, yes – 41.6 (1761)
Mean (SD) BMI at enrolment, kg/m2 24.5 (4.2) 25.3 (3.4)
History of asthma or atopy, yes 37.7 (1594) 33.7 (1425)
Pet keeping, yes 35.9 (1520) –
Psychological distress during pregnancy
  Overall psychological distress, 
continuously*
0.15 (0.00 to 0.91) 0.08 (0.00 to 0.55)
  Overall psychological distress, yes 8.6 (362) 3.9 (167)
  Depressive symptoms, continuously* 0.00 (0.00 to 1.00) 0.00 (0.00 to 0.67)
  Depressive symptoms, yes 8.2 (348) 4.3 (182)
  Anxiety symptoms, continuously* 0.17 (0.00 to 1.00) 0.00 (0.00 to 0.75)
  Anxiety symptoms, yes 9.3 (395) 8.0 (337)
Psychological distress at 2 months after 
pregnancy
  Overall psychological distress, 
continuously*
0.13 (0.00 to 0.93) –
  Overall psychological distress, yes 7.9 (333) –
  Depressive symptoms, continuously* 0.00 (0.00 to 1.08) –
  Depressive symptoms, yes 8.2 (349) –
  Anxiety symptoms, continuously* 0.00 (0.00 to 1.00) –
  Anxiety symptoms, yes 8.3 (350) –
Psychological distress at 6 months after 
pregnancy
  Depressive symptoms, continuously* 0.17 (0.00 to 1.17) –
  Depressive symptoms, yes 8.5 (358) –
  Anxiety symptoms, continuously* 0.00 (0.00 to 1.17) –
  Anxiety symptoms, yes 9.9 (417) –
Psychological distress at 36 months 
after pregnancy
  Depressive symptoms, continuously* 0.00 (0.00 to 0.78) 0.00 (0.00 to 0.68)
  Depressive symptoms, yes 5.1 (217) 4.4 (187)
  Anxiety symptoms, continuously* 0.00 (0.00 to 0.80) 0.00 (0.00 to 0.68)
  Anxiety symptoms, yes 5.1 (214) 7.7 (324)
Data on maternal depressive (n=5) and anxiety (n=6) symptoms during pregnancy 
were missing and not imputed.
Values are means (SD),
*medians (5%–95% range), or valid percentages (absolute numbers).
–, not all information was available for both mothers and fathers; BMI, body mass 
index.
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only maternal depressive symptoms during pregnancy were 
associated with a lower FEV1 and FVC (−0.13 (95% CI −0.24 
to –0.01) and −0.13 (95% CI −0.24 to –0.02), respectively). 
Additional adjustment for paternal psychological distress during 
pregnancy did not change the direction or magnitude of the 
effect (table 4). When we additionally adjusted for maternal 
psychological distress at 2, 6 and 36 months after pregnancy 
and paternal psychological distress 36 months after pregnancy, 
the size and direction of the associations of depressive symp-
toms with a lower FEV1 and FVC remained unchanged, except 
when adjusting for maternal psychological distress at 2 months 
(table 5). The percentage changes in effect estimates were, 
however, non- significant (data not shown).
Maternal overall psychological distress and depressive and 
anxiety symptoms during pregnancy were all associated with an 
increased risk of current asthma in their children, both continu-
ously and when using clinical cut- offs (range OR 1.46 (95% CI 
1.12 to 1.90) to 1.91 (95% CI 1.26 to 2.91)) (table 3). When we 
additionally adjusted for paternal psychological distress during 
pregnancy, the associations of maternal psychological distress 
with childhood asthma remained essentially unchanged (table 4). 
Additional adjustment for maternal psychological distress at 2, 
6 and 36 months after pregnancy did not change the direction 
or magnitude of the effect estimates for the association with 
asthma, including a non- significant percentage change in effect 
estimates (table 5). Analysis of patterns of psychological distress 
showed that mostly depressive or anxiety symptoms both during 
and after pregnancy are associated with an increased risk of 
asthma in children (online supplementary table S3). Separating 
the confounders into three different groups, including lifestyle 
and health- related factors, socioeconomic factors and birth and 
early childhood factors, showed no differences in size or direc-
tion of effect estimates of the associations of maternal psycholog-
ical distress with asthma in their children (online supplementary 
table S4). However, lifestyle and health- related factors seemed 
to account for attenuation of the effect of maternal psycholog-
ical distress with FEF75 only.
Paternal psychological distress, lung function and asthma
Paternal psychological distress during pregnancy was not associ-
ated with lung function or asthma in their children (table 6). The 
associations of paternal psychological distress during pregnancy 
with lung function and asthma remained essentially unchanged 
after additional adjustment for paternal psychological distress 
at 36 months after pregnancy (online supplementary table S5). 
Only the associations of clinical cut- offs of anxiety with FEV1 
and FVC became significant, as opposed to before adjustment 
for paternal psychological distress after birth (−0.15 (95% CI 
−0.29 to –0.00) and −0.14 (95% CI −0.29 to –0.00), respec-
tively). However, the percentage changes for these and other 
Table 2 Characteristics of children
n=4231
Sex, female 51.2 (2166)
Gestational age at birth, weeks* 40.1 (37.1–42.1)
Birth weight (g) 3450 (545)
Ethnicity, non- European 29.1 (1233)
Ever breastfeeding, yes 90.9 (3847)
Day care attendance first year, yes 57.4 (2428)
FEV1, L 2.02 (0.30)
FVC, L 2.33 (0.36)
FEV1/FVC, % 86.72 (5.66)
FEF75, L/s 1.15 (0.35)
FEV1, z- score 0.17 (0.97)
FVC, z- score 0.21 (0.93)
FEV1/FVC, z- score −0.10 (0.94)
FEF75, z- score 0.04 (0.91)
Current asthma, yes 5.9 (213)
Lung function measures (n=474) and current asthma (n=591) were missing and not 
imputed.
Values are mean (SD),
*medians (5%–95% range) or valid percentages (absolute numbers).
FEF75, forced expiratory flow after exhaling 75% of FVC; FEV1, forced expiratory 
volume in 1 s; FVC, forced vital capacity.
Table 3 Associations of maternal psychological distress during pregnancy with lung function and asthma in children at age 10 years
N
FEV1
Z- score (95% CI)
n=3757
FVC
Z- score (95% CI)
n=3757
FEV1/FVC
Z- score (95% CI)
n=3757
FEF75






Overall psychological distress 4231
  Per 1- unit increase −0.07 (−0.17 to 0.03) −0.10 (−0.20 to −0.01)* 0.04 (−0.06 to 0.13) 0.01 (−0.08 to 0.10) 1.83 (1.30 to 2.59)**
  Clinical cut- off −0.02 (−0.14 to 0.10) −0.07 (−0.14 to 0.01) 0.03 (−0.05 to 0.10) 0.02 (−0.05 to 0.09) 1.91 (1.26 to 2.91)**
Depressive symptoms 4225
  Per 1- unit increase −0.05 (−0.12 to 0.03) −0.07 (−0.14 to 0.01) 0.03 (−0.04 to 0.11) 0.02 (−0.05 to 0.09) 1.46 (1.12 to 1.90)**
  Clinical cut- off −0.13 (−0.24 to −0.01)* −0.13 (−0.24 to −0.02)* −0.01 (−0.12 to 0.11) −0.03 (−0.14 to 0.08) 1.84 (1.21 to 2.80)**
Anxiety symptoms 4226
  Per 1- unit increase −0.01 (−0.09 to 0.07) −0.03 (−0.10 to 0.05) 0.01 (−0.07 to 0.09) −0.00 (−0.07 to 0.07) 1.55 (1.19 to 2.02)**
  Clinical cut- off −0.01 (−0.12 to 0.10) 0.01 (−0.09 to 0.11) −0.05 (−0.16 to 0.06) −0.05 (−0.15 to 0.05) 1.64 (1.09 to 2.47)*
Values are z- scores or odds ratios (OR) with 95% CIs from linear or logistic regression models, respectively.
Maternal psychological distress is treated as a continuous variable (per 1- unit increase) or a dichotomous variable based on clinical cut- offs (no; yes, where ‘no’ was the 
reference category).
The main models were adjusted for maternal age, parity, education level, smoking during pregnancy, body mass index at enrolment, history of asthma or atopy and pet keeping, 
and child’s sex, gestational age at birth, birth weight, ethnicity, breastfeeding and daycare attendance.
*P<0.05, **P<0.01.
FEF75, forced expiratory flow after exhaling 75% of FVC; FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity.
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associations, when adding paternal psychological distress after 
pregnancy to the model, were non- significant (online supple-
mentary table S6).
DISCUSSION
The results of this population- based prospective cohort study 
showed that children of mothers with overall psychological 
distress and depressive or anxiety symptoms during pregnancy 
had an increased risk of asthma at the age of 10 years. Children 
of mothers with overall psychological distress when measured 
continuously had a lower FVC, and children of mothers with 
depressive symptoms when using clinical cut- offs had a lower 
FEV1 and FVC. These findings were mostly independent of 
paternal psychological distress during pregnancy, and maternal 
and paternal psychological distress after pregnancy. The stron-
gest effects were found for mothers who experienced psycho-
logical distress both during and after pregnancy. Although the 
effects of distress during pregnancy only were not significant, 
this is most likely due to the power of the study, given that the 
effects estimates are in the same range as for the main analysis. 
Paternal psychological distress during pregnancy was not asso-
ciated with an increased risk of lower lung function or asthma. 
Our results may indicate an intrauterine effect of maternal 
psychological distress during pregnancy on fetal lung develop-
ment and respiratory morbidity rather than an effect of unmea-
sured genetic, social, behavioural or environmental factors.
Comparison with previous studies
Studies examining the association of maternal psychological 
distress with childhood lung function are scarce. One study 
found that high prenatal but also postnatal maternal psycho-
logical distress, measured as negative life events, was associated 
with a lower FEV1, FVC and mid- expiratory flow (FEF25-75) but 
not FEV1/FVC at age 7 years.
26 This is in line with our study, 
where we found that the association of maternal psychological 
distress with a lower FEV1 and FVC remains present in later 
childhood. These significant findings, compared with the more 
robust findings for the asthma outcome, are few and effect 
sizes are small from a clinical perspective but of importance 
from an aetiological perspective. Studies examining the asso-
ciation of maternal psychological stress during pregnancy with 
wheezing and asthma in children have been summarised in two 
recent meta- analyses.5 6 Both meta- analyses focused mostly on 
wheezing and asthma until preschool age, with only a few studies 
that measured respiratory outcomes after the age of 6 years. One 
meta- analysis including 10 studies found that maternal psycho-
logical stress during pregnancy was associated with a 1.56- fold 
increased risk of any respiratory morbidity in the children.5 
When the associations with asthma and wheezing were studied 
separately, the effect sizes were approximately in the same range, 
although the latter showed high heterogeneity. The other more 
recent meta- analysis including 24 studies demonstrated that any 
maternal psychological stress during pregnancy was associated 
with a 1.13- fold increased risk of asthma in the children.6 This 
was most likely driven by anxiety during pregnancy, since only 
this association was significant when different types of psycho-
logical distress were studied separately. Anxiety, depression and 
negative life events during pregnancy were all associated with 
an increased risk of wheezing (OR or RR 1.19, 1.74 and 1.23, 
respectively). Our study shows that maternal stress during preg-
nancy is associated with an increased risk of asthma even at a 
later age, with effect sizes within the same range. Additionally, 
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psychological distress during pregnancy and parental psycho-
logical distress after pregnancy, which was not studied in these 
meta- analyses.
Possible mechanisms
Our results suggest that intrauterine mechanisms may underlie 
Table 5 Associations of maternal psychological distress with lung function and asthma in children at age 10 years, adjusted for maternal 
psychological distress at 2, 6 and 36 months after pregnancy and paternal psychological distress at 36 months after pregnancy
N
FEV1
Z- score (95% CI)
n=3757
FVC
Z- score (95% CI)
n=3757
FEV1/FVC
Z- score (95% CI)
n=3757
FEF75





Main model + maternal 
psychological distress at 2 
months
  Overall psychological 
distress
4231
   Per 1- unit increase −0.03 (−0.15 to 0.09) −0.06 (−0.18 to 0.05) 0.05 (−0.08 to 0.17) 0.05 (−0.07 to 0.18) 2.01 (1.26 to 3.22)**
   Clinical cut- off 0.01 (−0.12 to 0.14) −0.02 (−0.15 to 0.10) 0.02 (−0.11 to 0.14) 0.06 (−0.06 to 0.18) 2.11 (1.30 to 3.43)**
  Depressive symptoms 4226
   Per 1- unit increase −0.02 (−0.11 to 0.06) −0.05 (−0.13 to 0.03) 0.04 (−0.05 to 0.12) 0.04 (−0.04 to 0.13) 1.37 (1.00 to 1.88)
   Clinical cut- off −0.12 (−0.23 to 0.01) −0.10 (−0.21 to 0.02) −0.04 (−0.16 to 0.09) −0.04 (−0.16 to 0.08) 1.87 (1.18 to 2.97)**
  Anxiety symptoms 4225
   Per 1- unit increase 0.00 (−0.09 to 0.09) −0.01 (−0.10 to 0.08) 0.00 (−0.09 to 0.10) 0.00 (−0.09 to 0.09) 1.70 (1.20 to 2.41)**
   Clinical cut- off −0.01 (−0.12 to 0.11) 0.02 (−0.09 to 0.13) −0.06 (−0.18 to 0.05) −0.05 (−0.16 to 0.06) 1.72 (1.09 to 2.72)*
Main model + maternal 
psychological distress at 6 
months
  Depressive symptoms 4226
   Per 1- unit increase −0.05 (−0.14 to 0.04) −0.06 (−0.14 to 0.03) 0.00 (0.08 to 0.09) 0.01 (−0.08 to 0.09) 1.29 (0.93 to 1.78)
   Clinical cut- off −0.13 (−0.26 to -0.01)* −0.13 (−0.24 to -0.01)* −0.02 (−0.15 to 0.10) −0.04 (−0.16 to 0.08) 1.58 (0.99 to 2.54)
  Anxiety symptoms 4225
   Per 1- unit increase −0.04 (−0.13 to 0.04) −0.04 (−0.13 to 0.04) −0.02 (−0.11 to 0.07) −0.02 (−0.11 to 0.06) 1.61 (1.16 to 2.22)**
   Clinical cut- off −0.02 (−0.13 to 0.09) −0.01 (−0.11 to 0.12) −0.07 (−0.18 to 0.05) −0.06 (−0.17 to 0.05) 1.59 (1.02 to 2.48)*
Main model + maternal 
psychological distress at 36 
months
  Depressive symptoms 4226
   Per 1- unit increase −0.05 (−0.13 to 0.04) −0.07 (−0.15 to 0.01) 0.03 (−0.05 to 0.11) 0.03 (−0.06 to 0.11) 1.38 (1.02 to 1.86)*
   Clinical cut- off −0.12 (−0.24 to −0.00)* −0.12 (−0.24 to −0.01)* −0.01 (−0.13 to 0.11) −0.02 (−0.14 to 0.09) 1.78 (1.14 to 2.78)*
  Anxiety symptoms 4225
   Per 1- unit increase −0.03 (−0.11 to 0.06) −0.03 (−0.12 to 0.05) −0.00 (−0.09 to 0.08) −0.01 (−0.09 to 0.07) 1.43 (1.05 to 1.95)*
   Clinical cut- off −0.01 (−0.12 to 0.10) 0.01 (−0.10 to 0.12) −0.06 (−0.17 to 0.06) −0.05 (−0.15 to 0.06) 1.52 (0.99 to 2.34)
Main model + paternal 
psychological distress at 36 
months
  Depressive symptoms 4226
   Per 1- unit increase −0.05 (−0.12 to 0.03) −0.07 (−0.14 to 0.00) 0.03 (−0.05 to 0.11) 0.02 (−0.05 to 0.10) 1.41 (1.07 to 1.86)*
   Clinical cut- off −0.13 (−0.24 to −0.01)* −0.13 (−0.24 to −0.02)* −0.00 (−0.12 to 0.11) −0.03 (−0.14 to 0.08) 1.78 (1.16 to 2.74)*
  Anxiety symptoms 4225
   Per 1- unit increase −0.02 (−0.09 to 0.06) −0.03 (−0.11 to 0.04) 0.01 (−0.07 to 0.09) −0.00 (−0.08 to 0.07) 1.51 (1.15 to 1.99)**
   Clinical cut- off −0.01 (−0.12 to 0.10) 0.01 (−0.10 to 0.11) −0.05 (−0.16 to 0.06) −0.05 (−0.15 to 0.05) 1.60 (1.06 to 2.41)*
Values are z- scores or odds ratios (OR) with 95% CIs from linear or logistic regression models, respectively.
Maternal psychological distress is treated as a continuous variable (per 1- unit increase) or a dichotomous variable based on clinical cut- offs (no; yes, where ‘no’ was the 
reference category).
The main models were adjusted for maternal age, parity, education level, smoking during pregnancy, body mass index at enrolment, history of asthma or atopy and pet keeping, 
and child’s sex, gestational age at birth, birth weight, ethnicity, breastfeeding and daycare attendance. Additionally, models were adjusted for maternal psychological distress at 
2, 6 or 36 months after pregnancy or for paternal psychological distress at 36 months after pregnancy. At 6 and 36 months after pregnancy, not all subscales were measured and 
therefore overall psychological distress could not be included at these time points.
*P<0.05, **P<0.01.
FEF75, forced expiratory flow after exhaling 75% of FVC; FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity.
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the associations of maternal psychological distress with child-
hood lung function and asthma in their children, rather than 
unmeasured genetic, social, behavioural or environmental 
factors. One potential intrauterine mechanism is excess gluco-
corticoid production due to maternal psychological distress, 
which could lead to impaired development of the fetal HPA 
axis.8 Additionally, maternal psychological distress could influ-
ence the stimulation of corticotrophin releasing hormone 
(CRH) secretion, which results in increased CRH levels in the 
fetal circulation and could overstimulate the fetal HPA axis. 
Moreover, glucocorticoid- regulated genes are key to fetal lung 
development, especially during the first and second trimesters 
of pregnancy.9 Any disruption in this process could lead to 
developmental adaptations of the lungs and, hence, altered lung 
function.
Epigenetics has also been proposed as a possible mechanism. 
It has been shown that maternal depression and anxiety are 
associated with methylation of the glucocorticoid receptor gene 
NR3C1 in cord blood.27 Additionally, one study demonstrated 
an association of prenatal maternal stress with differently meth-
ylated regions related to the HPA axis, immune responses and 
lung organogenesis.28
Finally, oxidative stress and the microbiome have been spec-
ulated as possible underlying mechanisms for the association 
of maternal psychological distress during pregnancy with lung 
function and asthma in their offspring.29–31 However, these 
mechanisms should be studied in more detail.
Strengths and limitations of the study
The major strength of this study is the use of a large population- 
based prospective cohort with follow- up until school age. In our 
study, we used a well- known measure of psychological distress 
frequently used in epidemiological studies to assess psycholog-
ical distress at multiple time points, both continuously and with 
clinical cut- offs. Additionally, we adjusted for multiple possible 
confounding factors and considered paternal psychological 
distress to assess unmeasured confounding factors. Some meth-
odological limitations should be discussed. As in any prospective 
cohort study, our population was subject to loss to follow- up. 
Of those with singleton liveborn children with consent at age 10 
years, 73% responded to the questionnaire measuring psycho-
logical distress. This loss to follow- up could lead to bias if the 
associations of maternal psychological distress during pregnancy 
with lung function and asthma were different between those 
included and those not included in the study. This could lead to 
both an underestimation or an overestimation of the association 
and, although this is unlikely, it cannot be excluded.32 Addition-
ally, self- reporting of exposure and outcomes could potentially 
lead to information bias which could result in misclassification. 
The use of validated questionnaires could have minimised the 
information bias. The prevalence of asthma seems relatively low, 
but lies within national and worldwide prevalence rates.33 34 
We consider self- reported asthma as truly asthma because ques-
tions were based on the validated ISAAC questionnaire, and 
wheezing or asthma medication use in the past 12 months was 
used to better define current asthma. Also, the results were 
similar when we used persistent asthma as an outcome (data 
not shown). Moreover, psychological distress was measured 
only once during pregnancy. Hence, we do not know whether 
maternal psychological distress varied in intensity or persistence 
throughout pregnancy. However, one study that measured 
maternal anxiety at two time points during pregnancy demon-
strated associations with asthma that were comparable for both 
time points, suggesting that timing in pregnancy seems to have 
a less prominent role in prenatal programming.2 Further studies 
are needed to confirm these results. Lastly, although we adjusted 
for numerous confounders, we might not have had information 
on all possible confounding factors such as maternal or child 
genetic predisposition for psychological stress disorders or child-
hood exposures such as air pollution. Although some of their 
effects might be minimal and are highly correlated with pres-
ently used confounders, they could potentially have a substantial 
effect given the relatively small prevalence of asthma.
CONCLUSION
Our results suggest a possible intrauterine effect of maternal 
psychological distress during pregnancy on the risk of asthma 
and partly lower lung function in children at the age of 10 years. 
The results were independent of maternal psychological distress 
after pregnancy and paternal psychological distress during 
Table 6 Associations of paternal psychological distress with lung function and asthma in children at age 10 years
N
FEV1
Z- score (95% CI)
n=3757
FVC
Z- score (95% CI)
n=3757
FEV1/FVC
Z- score (95% CI)
n=3757
FEF75






  Overall psychological distress 4231
   Per 1- unit increase 0.00 (−0.18 to 0.18) −0.05 (−0.23 to 0.13) 0.07 (−0.08 to 0.22) 0.03 (−0.13 to 0.19) 1.13 (0.56 to 2.26)
   Clinical cut- off −0.05 (−0.30 to 0.20) −0.08 (−0.31 to 0.14) 0.04 (−0.17 to 0.24) −0.04 (−0.25 to 0.17) 0.98 (0.44 to 2.18)
  Depressive symptoms 4231
   Per 1- unit increase −0.02 (−0.18 to 0.14) −0.04 (−0.19 to 0.11) 0.02 (−0.10 to 0.14) −0.01 (−0.16 to 0.13) 1.04 (0.59 to 1.85)
   Clinical cut- off −0.07 (−0.30 to 0.16) −0.07 (−0.30 to 0.16) −0.02 (−0.20 to 0.17) −0.06 (−0.25 to 0.13) 1.04 (0.43 to 2.53)
  Anxiety symptoms 4231
   Per 1- unit increase −0.01 (−0.17 to 0.15) −0.03 (−0.19 to 0.14) 0.02 (−0.10 to 0.14) −0.01 (−0.14 to 0.13) 0.85 (0.46 to 1.58)
   Clinical cut- off −0.13 (−0.28 to 0.02) −0.13 (−0.27 to 0.01) 0.01 (−0.14 to 0.15) −0.06 (−0.21 to 0.09) 0.99 (0.51 to 1.92)
Values are z- scores or odds ratios (OR) with 95% CIs from linear or logistic regression models, respectively.
Paternal psychological distress is treated as a continuous variable (per 1- unit increase) or a dichotomous variable based on clinical cut- offs (no; yes, where ‘no’ was the reference 
category).
The models were adjusted for maternal age, parity, education level, smoking during pregnancy, body mass index at enrolment, history of asthma or atopy and pet keeping, and 
child’s sex, gestational age at birth, birth weight, ethnicity, breastfeeding and daycare attendance and maternal psychological distress during pregnancy.
FEF75, forced expiratory flow after exhaling 75% of FVC; FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity.
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pregnancy and after pregnancy. Further studies are needed to 
explore underlying mechanisms.
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